"Designing Growth Strategies is in our DNA"
Table 01: U.S. Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, By Drug Class, 2019–2030
Table 02: U.S. Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, By Anti-glaucoma, 2019–2030
Table 03: U.S. Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, By Dosage Form, 2019–2030
Table 04: U.S. Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Disease Indication, 2019–2030
Table 05: U.S. Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Glaucoma, 2019–2030
Table 06: U.S. Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Retinal Diseases, 2019–2030
Table 07: U.S. Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2030
Figure 01: U.S. Ophthalmic Disease Therapeutics Market Revenue Breakdown (USD billion, %) by Type, 2022 & 2030
Figure 02: U.S. Ophthalmic Disease Therapeutics Market Value Share (%), by Drug Class, 2022 & 2030
Figure 03: U.S. Ophthalmic Disease Therapeutics Market Value Share (%), by Dosage Form, 2022 & 2030
Figure 04: U.S. Ophthalmic Disease Therapeutics Market Value Share (%), by Disease Indication, 2022 & 2030
Figure 05: U.S. Ophthalmic Disease Therapeutics Market Value Share (%), by Distribution Channel, 2022 & 2030
Figure 06: U.S. Ophthalmic Disease Therapeutics Market Share (%), By Company, 2022
Related Reports